Allergan has announced a new information campaign to inform women about last year’s Biocell breast implant recall and to urge them to register on an informational website so their implants can be identified.…
Amid reports of severe brain inflammation and deaths linked to side effects of Zinbryta, the multiple sclerosis drug was recalled globally in early March 2018. As a result of the drug makers failure to warn about the risk of encephalitis, meningoencephalitis and other problems, Zinbryta lawsuits are being evaluated by product liability lawyers. STATUS OF ZINBRYTA LAWSUITS: Lawyers are evaluating whether financial compensation may be available for individuals who have experienced any of the following complications following use of Zinbryta: Encephalitis Meningoencephalitis Other Sudden Brain Inflammation Wrongful Death >>SUBMIT INFO TO A ZINBRYTA LAWYER<< MANUFACTURERS: AbbVie, Inc. and Biogen, Inc.…
The FDA warns that clinical trials indicate Venclexta can increase the risk of death when given off-label to patients for the treatment of multiple myeloma.…
All AndroGel claims have been stayed by a federal judge following an announcement that parties were close to a global settlement agreement.…
A $140 million verdict in an AndroGel heart attack lawsuit has been overturned by a federal judge, who has ordered a new trial this fall.…
Endo International has finalized a Testim testosterone gel settlement agreement which will resolve about 1,300 lawsuits over heart attack and stroke injury claims.…
European regulators say they have positively confirmed that the recently recalled MS drug Zinbryta had health risks that outweighed any potential benefits, indicating that causes of severe brain inflammation were impossible to predict.…
A federal jury has ruled in favor of AbbVie in the latest AndroGel bellwether lawsuit to go to trial.…
A new study indicates that Zinbryta side effects were so severe it could have never become a major drug product, raising questions as to why it was approved when there were less dangerous alternatives.…
The next AndroGel trial is set for May 7 and will address claims by an Arizona man that the testosterone gel caused him to suffer a pulmonary embolism.…
